Artificial intelligence for synthetic functional genomics of blood

This project aims to develop predictive models of gene regulatory elements and networks using deep learning and single-cell genetic screens to enhance gene regulation in hematopoiesis.

Subsidie
€ 1.499.653
2022

Projectdetails

Introduction

Our abilities to predict and engineer complex biological systems are in their infancy. In the context of gene regulation, we cannot design artificial promoters with specificity to arbitrary cell states, and we cannot arbitrarily trans- and de-differentiate somatic cells, although such abilities would be of high biotechnological and biomedical value.

Objectives

To achieve these ambitious goals, we require quantitative, predictive models of gene regulatory elements (GREs) and gene regulatory networks (GRNs), respectively. Here I propose that the combination of deep learning and single-cell genetic screens is ideally suited to obtain such models, and, in particular, the amounts of highly informative data required for their training.

Methodology

Screening of Synthetic GREs

Working with an ex vivo model of hematopoietic stem cell differentiation, we will first screen the activity of hundreds of thousands of synthetic GREs throughout the hematopoietic differentiation landscape.

  • This will allow us to obtain models of cell type specific GRE activity that can predict new, synthetic GREs with activity in any cell state of interest.

Screening of GRN Perturbations

Second, we will screen hundreds of thousands of combinatorial GRN perturbations and their effect on cell state.

  • Thereby, we will derive models of GRNs that can predict combinatorial perturbation strategies to achieve arbitrary de- or trans-differentiation events.

Conclusion

In sum, work on this project will yield a quantitative model of gene regulation in hematopoiesis at various scales of complexity while introducing a novel, AI-guided concept for biological engineering.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.653
Totale projectbegroting€ 1.499.653

Tijdlijn

Startdatum1-9-2022
Einddatum31-8-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • FUNDACIO CENTRE DE REGULACIO GENOMICApenvoerder

Land(en)

Spain

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Designing synthetic regulatory domains to understand gene expression

This project aims to uncover gene regulation mechanisms by systematically altering and analyzing synthetic gene regulatory domains in mouse stem cells to reveal insights into non-coding genome organization.

€ 1.500.000
ERC Advanced...

Decoding animal genomes into cell types

This project aims to decode how genome sequences translate into cell types using Drosophila, employing deep learning and multi-omics to understand regulatory programs and their evolutionary changes.

€ 2.500.000
ERC Advanced...

Learning and modeling the molecular response of single cells to drug perturbations

DeepCell aims to model cellular responses to drug perturbations using multiomics and deep learning, facilitating optimal treatment design and expediting drug discovery in clinical settings.

€ 2.497.298
ERC Advanced...

Cellular models for tissue function in development and ageing

Develop a computational framework to model cellular interactions in tissues, enabling insights into dynamics and gene regulation for applications in cell engineering and immunotherapy.

€ 2.937.179
ERC Starting...

Shedding light on three-dimensional gene regulation

This project aims to elucidate gene expression regulation during differentiation using an ultra-fast optogenetic system and high-resolution genomic tools to study 3D chromatin interactions.

€ 1.500.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application

This project aims to innovate hematopoietic stem cell identification and engineering through advanced culture techniques and multiomics profiling, enhancing gene therapy for blood disorders and cancer.

€ 3.797.562